VBI Vaccines Inc.

NASDAQ:VBIV   3:59:56 PM EDT
1.83
-0.02 (-1.08%)
5:20:31 PM EDT: $1.84 +0.01 (+0.55%)
Products

VBI Vaccines Granted FDA Fast Track Designation For Vbi-1901 To Treat Recurrent GBM

Published: 06/08/2021 13:29 GMT
VBI Vaccines Inc. (VBIV) - Vbi Vaccines Granted FDA Fast Track Designation for Vbi-1901 for the Treatment of Recurrent Gbm.
Vbi Vaccines Inc - Designation Granted Based on Data From Phase 1/2a Study of Vbi-1901 in Recurrent Gbm Patients.